References
[1] Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR,
Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK,
Slotwiner DJ, Stevenson LW, Varosy PD, Welikovitch L: HRS/ACC/AHA expert
consensus statement on the use of implantable cardioverter-defibrillator
therapy in patients who are not included or not well represented in
clinical trials. Circulation 2014; 130:94-125.
[2] Matthews JC, Betley D, Morady F, Pelosi F, Jr.: Adverse
interaction between a left ventricular assist device and an implantable
cardioverter defibrillator. J Cardiovasc Electrophysiol 2007;
18:1107-1108.
[3] Jacob S, Cherian PK, Ghumman WS, Das MK: ”Pseudo” Faraday cage:
a solution for telemetry link interaction between a left ventricular
assist device and an implantable cardioverter defibrillator. J Interv
Card Electrophysiol 2010; 28:221-225.
[4] Oswald H, Klein G, Struber M, Gardiwal A: Implantable
defibrillator with left ventricular assist device compatibility.
Interact Cardiovasc Thorac Surg 2009; 8:579-580.
[5] Murphy M, Welch T, Shaw PW, Kennedy JLW, Bilchick KC: Inhibition
of pacing in a dependent patient with an implantable
cardioverter-defibrillator and a left ventricular assist device.
HeartRhythm Case Rep 2016; 2:473-477.
[6] Netzler PC, Vasuki N, Peura JL, Gold MR: Interactions between a
left ventricular assist device and implantable
cardioverter-defibrillator. Pacing Clin Electrophysiol 2012;
35:e272-273.
[7] Sehatbakhsh S, Kushnir A, Chait R, Ghumman W: Electromagnetic
Interference between Subcutaneous ICD and HeartMate II LVAD. Journal of
Cardiac Failure 2018; 24:S12.
[8] Erqou S, Kormos RL, Wang NC, McNamara DM, Bazaz R:
Electromagnetic Interference from Left Ventricular Assist Device (LVAD)
Inhibiting the Pacing Function of an Implantable
Cardioverter-Defibrillator (ICD) Device. Case Rep Cardiol 2018;
2018:6195045.
[9] Mozes A, DeNofrio D, Pham DT, Homoud MK: Inappropriate
implantable cardioverter-defibrillator therapy due to electromagnetic
interference in patient with a HeartWare HVAD left ventricular assist
device. Heart Rhythm 2011; 8:778-780.
[10] Saeed D, Albert A, Westenfeld R, Maxhera B, Gramsch-Zabel H,
O’Connor S, Lichtenberg A, Winter J: Left ventricular assist device in a
patient with a concomitant subcutaneous implantable cardioverter
defibrillator. Circ Arrhythm Electrophysiol 2013; 6:e32-33.
[11] Ahmed AS, Patel PJ, Bagga S, Gilge JL, Schleeter T, Lakhani BA,
Ravichandran AK, Donnelley S, Allavatam V, Prystowsky EN, Padanilam BJ:
Troubleshooting electromagnetic interference in a patient with
centrifugal flow left ventricular assist device and subcutaneous
implantable cardioverter defibrillator. J Cardiovasc Electrophysiol
2018; 29:477-481.
[12] Chhabra L, Hiendlmayr B, Kluger J: An Adverse
Electrophysiological Interaction Between an Implantable
Cardioverter-Defibrillator and a Ventricular Assist Device. Connecticut
medicine 2015; 79:351-354.
[13] Lopez-Gil M, Fontenla A, Delgado JF, Rodriguez-Munoz D:
Subcutaneous implantable cardioverter defibrillators in patients with
left ventricular assist devices: case report and comprehensive review.
Eur Heart J Case Rep 2019; 3.
[14] Schukro C, Schloglhofer T, Khazen C, Rohrich M, Laufer G,
Zimpfer D, Wiedemann D: Influence of a fully magnetically levitated left
ventricular assist device on functional interrogation of implantable
cardioverter defibrillators. Clin Cardiol 2019; 42:914-918.
[15] Pfeffer TJ, Konig T, Duncker D, Michalski R, Hohmann S, Oswald
H, Schmitto JD, Veltmann C: Subcutaneous Implantable
Cardioverter-Defibrillator Shocks After Left Ventricular Assist Device
Implantation. Circ Arrhythm Electrophysiol 2016; 9.